232 related articles for article (PubMed ID: 22317749)
41. Listeriolysin O: A phagosome-specific cytolysin revisited.
Nguyen BN; Peterson BN; Portnoy DA
Cell Microbiol; 2019 Mar; 21(3):e12988. PubMed ID: 30511471
[TBL] [Abstract][Full Text] [Related]
42. The Production of Listeriolysin O and Subsequent Intracellular Infections by
Rinehart E; Chapman J; Sun Y
Toxins (Basel); 2020 Mar; 12(4):. PubMed ID: 32235519
[No Abstract] [Full Text] [Related]
43. Listeria monocytogenes and Shigella flexneri Activate the NLRP1B Inflammasome.
Neiman-Zenevich J; Stuart S; Abdel-Nour M; Girardin SE; Mogridge J
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808162
[TBL] [Abstract][Full Text] [Related]
44. Elimination of the listeriolysin O-directed immune response by conservative alteration of the immunodominant listeriolysin O amino acid 91 to 99 epitope.
Bouwer HG; Moors M; Hinrichs DJ
Infect Immun; 1996 Sep; 64(9):3728-35. PubMed ID: 8751922
[TBL] [Abstract][Full Text] [Related]
45. Human T-cell recognition of Listeria monocytogenes: recognition of listeriolysin O by TcR alpha beta + and TcR gamma delta + T cells.
Guo Y; Ziegler HK; Safley SA; Niesel DW; Vaidya S; Klimpel GR
Infect Immun; 1995 Jun; 63(6):2288-94. PubMed ID: 7768611
[TBL] [Abstract][Full Text] [Related]
46. Biological effects of listeriolysin O: implications for vaccination.
Hernández-Flores KG; Vivanco-Cid H
Biomed Res Int; 2015; 2015():360741. PubMed ID: 25874208
[TBL] [Abstract][Full Text] [Related]
47. Passive immunization with anti-ActA and anti-listeriolysin O antibodies protects against Listeria monocytogenes infection in mice.
Asano K; Sashinami H; Osanai A; Hirose S; Ono HK; Narita K; Hu DL; Nakane A
Sci Rep; 2016 Dec; 6():39628. PubMed ID: 28004800
[TBL] [Abstract][Full Text] [Related]
48. Stress-induced ClpP serine protease of Listeria monocytogenes is essential for induction of listeriolysin O-dependent protective immunity.
Gaillot O; Bregenholt S; Jaubert F; Di Santo JP; Berche P
Infect Immun; 2001 Aug; 69(8):4938-43. PubMed ID: 11447171
[TBL] [Abstract][Full Text] [Related]
49. Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles.
Birmingham CL; Canadien V; Kaniuk NA; Steinberg BE; Higgins DE; Brumell JH
Nature; 2008 Jan; 451(7176):350-4. PubMed ID: 18202661
[TBL] [Abstract][Full Text] [Related]
50. Capacity of ivanolysin O to replace listeriolysin O in phagosomal escape and in vivo survival of Listeria monocytogenes.
Frehel C; Lety MA; Autret N; Beretti JL; Berche P; Charbit A
Microbiology (Reading); 2003 Mar; 149(Pt 3):611-620. PubMed ID: 12634330
[TBL] [Abstract][Full Text] [Related]
51. Multiple mechanisms contribute to the robust rapid gamma interferon response by CD8+ T cells during Listeria monocytogenes infection.
Bou Ghanem EN; McElroy DS; D'Orazio SE
Infect Immun; 2009 Apr; 77(4):1492-501. PubMed ID: 19179413
[TBL] [Abstract][Full Text] [Related]
52. An in silico DNA vaccine against Listeria monocytogenes.
Jahangiri A; Rasooli I; Gargari SL; Owlia P; Rahbar MR; Amani J; Khalili S
Vaccine; 2011 Sep; 29(40):6948-58. PubMed ID: 21791233
[TBL] [Abstract][Full Text] [Related]
53. Role of listeriolysin-O (LLO) in the T lymphocyte response to infection with Listeria monocytogenes. Identification of T cell epitopes of LLO.
Safley SA; Cluff CW; Marshall NE; Ziegler HK
J Immunol; 1991 May; 146(10):3604-16. PubMed ID: 1709197
[TBL] [Abstract][Full Text] [Related]
54. Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine.
Kono M; Nakamura Y; Suda T; Uchijima M; Tsujimura K; Nagata T; Giermasz AS; Kalinski P; Nakamura H; Chida K
Vaccine; 2012 Mar; 30(16):2633-9. PubMed ID: 22365841
[TBL] [Abstract][Full Text] [Related]
55. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
Sewell DA; Shahabi V; Gunn GR; Pan ZK; Dominiecki ME; Paterson Y
Cancer Res; 2004 Dec; 64(24):8821-5. PubMed ID: 15604239
[TBL] [Abstract][Full Text] [Related]
56. Regulated translation of listeriolysin O controls virulence of Listeria monocytogenes.
Schnupf P; Hofmann J; Norseen J; Glomski IJ; Schwartzstein H; Decatur AL
Mol Microbiol; 2006 Aug; 61(4):999-1012. PubMed ID: 16859495
[TBL] [Abstract][Full Text] [Related]
57. The pore-forming toxin listeriolysin O is degraded by neutrophil metalloproteinase-8 and fails to mediate Listeria monocytogenes intracellular survival in neutrophils.
Arnett E; Vadia S; Nackerman CC; Oghumu S; Satoskar AR; McLeish KR; Uriarte SM; Seveau S
J Immunol; 2014 Jan; 192(1):234-44. PubMed ID: 24319266
[TBL] [Abstract][Full Text] [Related]
58. The Listeriolysin O PEST-like Sequence Co-opts AP-2-Mediated Endocytosis to Prevent Plasma Membrane Damage during Listeria Infection.
Chen C; Nguyen BN; Mitchell G; Margolis SR; Ma D; Portnoy DA
Cell Host Microbe; 2018 Jun; 23(6):786-795.e5. PubMed ID: 29902442
[TBL] [Abstract][Full Text] [Related]
59. Purification and characterization of a recombinant listeriolysin O expressed in Escherichia coli and possible diagnostic applications.
Giammarini C; Andreoni F; Amagliani G; Casiere A; Barocci S; Magnani M
J Biotechnol; 2004 Apr; 109(1-2):13-20. PubMed ID: 15063610
[TBL] [Abstract][Full Text] [Related]
60. Activation of the unfolded protein response by Listeria monocytogenes.
Pillich H; Loose M; Zimmer KP; Chakraborty T
Cell Microbiol; 2012 Jun; 14(6):949-64. PubMed ID: 22321539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
